To investigate whether Vpr peptides can induce ICD in tumor cells, we used three tumor cell lines with different immunogenicity, MC38, B16F10, and LLC [53], and evaluated the three hallmarks of ICD, namely, CRT, ATP, and HMGB1 after Vpr peptide treatment. This evidence concerns the gene HMGB1 and neoplasm.